347 related articles for article (PubMed ID: 31821597)
1. Fetal fraction and noninvasive prenatal testing: What clinicians need to know.
Hui L; Bianchi DW
Prenat Diagn; 2020 Jan; 40(2):155-163. PubMed ID: 31821597
[TBL] [Abstract][Full Text] [Related]
2. A statistical investigation of parameters associated with low cell-free fetal DNA fraction in maternal plasma for noninvasive prenatal testing.
Pan Y; Pan X; Zhuang D; Zhou Y; Xue J; Wu S; Chen C; Li H
J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2338440. PubMed ID: 38604949
[TBL] [Abstract][Full Text] [Related]
3. Non-invasive prenatal testing for aneuploidy: current status and future prospects.
Benn P; Cuckle H; Pergament E
Ultrasound Obstet Gynecol; 2013 Jul; 42(1):15-33. PubMed ID: 23765643
[TBL] [Abstract][Full Text] [Related]
4. Combining the use of a fetal fraction-based risk algorithm and probability of an informative redraw in noninvasive prenatal testing for fetal aneuploidy.
Benn P; Martin K; McKanna T; Valenti E; Billings P; Demko Z
J Genet Couns; 2020 Oct; 29(5):800-806. PubMed ID: 31872514
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting cell-free DNA fetal fraction and the consequences for test accuracy.
Scott FP; Menezes M; Palma-Dias R; Nisbet D; Schluter P; da Silva Costa F; McLennan AC
J Matern Fetal Neonatal Med; 2018 Jul; 31(14):1865-1872. PubMed ID: 28514925
[TBL] [Abstract][Full Text] [Related]
6. Cell free DNA screening for fetal aneuploidy in Ireland: An observational study of outcomes following insufficient fetal fraction.
Creswell L; Doddy F; Manning C; Nazir SF; Lindow SW; Lynch C; O'Gorman N
Eur J Obstet Gynecol Reprod Biol; 2023 Nov; 290():143-149. PubMed ID: 37797414
[TBL] [Abstract][Full Text] [Related]
7. Sequencing shorter cfDNA fragments improves the fetal DNA fraction in noninvasive prenatal testing.
Qiao L; Yu B; Liang Y; Zhang C; Wu X; Xue Y; Shen C; He Q; Lu J; Xiang J; Li H; Zheng Q; Wang T
Am J Obstet Gynecol; 2019 Oct; 221(4):345.e1-345.e11. PubMed ID: 31125545
[TBL] [Abstract][Full Text] [Related]
8. Establishing and validating noninvasive prenatal testing procedure for fetal aneuploidies in Vietnam.
Phan MD; Nguyen TV; Trinh HNT; Vo BT; Nguyen TM; Nguyen NH; Nguyen TTQ; Do TTT; Hoang TTD; Truong KD; Giang H; Nguyen HN
J Matern Fetal Neonatal Med; 2019 Dec; 32(23):4009-4015. PubMed ID: 29865915
[No Abstract] [Full Text] [Related]
9. Cell-free DNA fetal fraction in twin gestations in single-nucleotide polymorphism-based noninvasive prenatal screening.
Hedriana H; Martin K; Saltzman D; Billings P; Demko Z; Benn P
Prenat Diagn; 2020 Jan; 40(2):179-184. PubMed ID: 31711265
[TBL] [Abstract][Full Text] [Related]
10. Fetal fraction of cell-free DNA in pregnancies after fresh or frozen embryo transfer following assisted reproductive technologies.
Talbot AL; Ambye L; Hartwig TS; Werge L; Sørensen S; Stormlund S; Prætorius L; Jørgensen HL; Pinborg A; Jørgensen FS
Hum Reprod; 2020 Jun; 35(6):1267-1275. PubMed ID: 32539141
[TBL] [Abstract][Full Text] [Related]
11. Total number of reads affects the accuracy of fetal fraction estimates in NIPT.
Miceikaitė I; Brasch-Andersen C; Fagerberg C; Larsen MJ
Mol Genet Genomic Med; 2021 Apr; 9(4):e1653. PubMed ID: 33687149
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive prenatal screening for patients with high body mass index: Evaluating the impact of a customized whole genome sequencing workflow on sensitivity and residual risk.
Muzzey D; Goldberg JD; Haverty C
Prenat Diagn; 2020 Feb; 40(3):333-341. PubMed ID: 31697845
[TBL] [Abstract][Full Text] [Related]
13. The Setup and Application of Reference Material in Sequencing-Based Noninvasive Prenatal Testing.
Qu S; Zhang Y; Yang X; Tan Y; Li M; Yang X; Zhou L; Chen D; Chen Y; Yan M; Wang Q; Yu T; Sun N; Jiang H; Su F; Di Y; Lin G; Yuan Y; Chen F; Mu F; Huang J
Gynecol Obstet Invest; 2021; 86(1-2):123-131. PubMed ID: 33784691
[TBL] [Abstract][Full Text] [Related]
14. Cell-free fetal DNA testing performance and fetal fraction estimation are not affected in ART-conceived pregnancies.
Balaguer N; Mateu-Brull E; Gómez-López M; Simón C; Milán M
Hum Reprod; 2022 Nov; 37(12):2743-2756. PubMed ID: 36223600
[TBL] [Abstract][Full Text] [Related]
15. Development of Reference Materials for Noninvasive Prenatal Aneuploidy Testing by Massively Parallel Sequencing: A Proof-of-Concept Study.
Blais J; Giroux S; Caron A; Clément V; Rousseau F
J Appl Lab Med; 2019 Jul; 4(1):50-60. PubMed ID: 31639707
[TBL] [Abstract][Full Text] [Related]
16. The significance of trisomy 7 mosaicism in noninvasive prenatal screening.
Qi Y; Yang J; Hou Y; Guo F; Peng H; Wang D; Du Q; Yin A
Hum Genomics; 2019 Apr; 13(1):18. PubMed ID: 30971315
[TBL] [Abstract][Full Text] [Related]
17. FF-QuantSC: accurate quantification of fetal fraction by a neural network model.
Yuan Y; Chai X; Liu N; Gu B; Li S; Gao Y; Zhou L; Liu Q; Yang F; Liu J; Qiu J; Zhang J; Hou Y; Cen M; Tian Z; Tang W; Zhang H; Chen F; Yin Y; Wang W
Mol Genet Genomic Med; 2020 Jun; 8(6):e1232. PubMed ID: 32281746
[TBL] [Abstract][Full Text] [Related]
18. Fetal fraction-based risk algorithm for non-invasive prenatal testing: screening for trisomies 13 and 18 and triploidy in women with low cell-free fetal DNA.
McKanna T; Ryan A; Krinshpun S; Kareht S; Marchand K; Grabarits C; Ali M; McElheny A; Gardiner K; LeChien K; Hsu M; Saltzman D; Stosic M; Martin K; Benn P
Ultrasound Obstet Gynecol; 2019 Jan; 53(1):73-79. PubMed ID: 30014528
[TBL] [Abstract][Full Text] [Related]
19. Obesity and no call results: optimal timing of cell-free DNA testing and redraw.
Hopkins MK; Koelper N; Caldwell S; Dyr B; Dugoff L
Am J Obstet Gynecol; 2021 Oct; 225(4):417.e1-417.e10. PubMed ID: 33839096
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive prenatal testing for fetal aneuploidies in the first trimester of pregnancy.
Song Y; Huang S; Zhou X; Jiang Y; Qi Q; Bian X; Zhang J; Yan Y; Cram DS; Liu J
Ultrasound Obstet Gynecol; 2015 Jan; 45(1):55-60. PubMed ID: 25044397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
